Cutler Group LP Eli Lilly & CO Put Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	SELL	$592.2 - $792.28 $2.19 Million - $2.93 Million	-3,700 Reduced 86.05%	600 $0
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $577,709 - $681,043	1,100 Added 34.38%	4,300 $10,000
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $347,760 - $479,439	-800 Reduced 20.0%	3,200 $55,000
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $1.4 Million - $1.88 Million	4,000 New	4,000 $70,000
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $5.72 Million - $6.67 Million	-17,800 Reduced 43.1%	23,500 $3,000
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $4.45 Million - $5.07 Million	-15,000 Reduced 26.64%	41,300 $126,000
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $4.96 Million - $5.83 Million	-17,800 Reduced 24.02%	56,300 $320,000
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $11.2 Million - $13.9 Million	47,600 Added 179.62%	74,100 $328,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $4.83 Million - $6 Million	21,500 Added 430.0%	26,500 $131,000
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $775,600 - $954,484	-3,500 Reduced 41.18%	5,000 $9,000
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $332,370 - $387,960	-3,000 Reduced 26.09%	8,500 $11,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $723,515 - $851,630	6,500 Added 130.0%	11,500 $3,000
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $394,956 - $493,626	4,600 Added 1150.0%	5,000 $0
Q4 2017 Jan 17, 2018	SELL	$81.94 - $87.89 $57,358 - $61,523	-700 Reduced 63.64%	400 $0
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $84,776 - $94,094	1,100	1,100 $1,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.